Letter by Hjemdahl Et Al Regarding Article, "Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial"
Circulation - United States
doi 10.1161/circulationaha.112.135343
Full Text
Open PDFAbstract
Available in full text
Date
March 19, 2013
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)